217 related articles for article (PubMed ID: 32894848)
1. Noninvasive Detection of Hemolysis with ETCOc Measurement in Neonates at Risk for Significant Hyperbilirubinemia.
Bhatia A; Chua MC; Dela Puerta R; Rajadurai VS
Neonatology; 2020; 117(5):612-618. PubMed ID: 32894848
[TBL] [Abstract][Full Text] [Related]
2. Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates.
Kaplan M; Herschel M; Hammerman C; Karrison T; Hoyer JD; Stevenson DK
Clin Chim Acta; 2006 Mar; 365(1-2):177-82. PubMed ID: 16188248
[TBL] [Abstract][Full Text] [Related]
3. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates.
Kaplan M; Herschel M; Hammerman C; Hoyer JD; Stevenson DK
Pediatrics; 2004 Aug; 114(2):e213-9. PubMed ID: 15286259
[TBL] [Abstract][Full Text] [Related]
4. An End-Tidal Carbon Monoxide Nomogram for Term and Late-Preterm Chinese Newborns.
Bao Y; Zhu J; Ma L; Zhang H; Sun L; Xu C; Wu J; He Y; Du L
J Pediatr; 2022 Nov; 250():16-21.e3. PubMed ID: 35835229
[TBL] [Abstract][Full Text] [Related]
5. Prediction of hyperbilirubinemia in near-term and term infants.
Stevenson DK; Fanaroff AA; Maisels MJ; Young BW; Wong RJ; Vreman HJ; MacMahon JR; Yeung CY; Seidman DS; Gale R; Oh W; Bhutani VK; Johnson LH; Kaplan M; Hammerman C; Nakamura H
J Perinatol; 2001 Dec; 21 Suppl 1():S63-72; discussion S83-7. PubMed ID: 11803421
[TBL] [Abstract][Full Text] [Related]
6. Prediction of hyperbilirubinemia in near-term and term infants.
Stevenson DK; Fanaroff AA; Maisels MJ; Young BW; Wong RJ; Vreman HJ; MacMahon JR; Yeung CY; Seidman DS; Gale R; Oh W; Bhutani VK; Johnson LH; Kaplan M; Hammerman C; Nakamura H
Pediatrics; 2001 Jul; 108(1):31-9. PubMed ID: 11433051
[TBL] [Abstract][Full Text] [Related]
7. Higher ETCOc predicts longer phototherapy treatment in neonatal hyperbilirubinemia.
Zhan YL; Peng HB; Jin ZC; Su JF; Tan XY; Zhao L; Zhang L
Front Pediatr; 2023; 11():1154350. PubMed ID: 37114002
[TBL] [Abstract][Full Text] [Related]
8. Corrected end-tidal carbon monoxide closely correlates with the corrected reticulocyte count in coombs' test-positive term neonates.
Javier MC; Krauss A; Nesin M
Pediatrics; 2003 Dec; 112(6 Pt 1):1333-7. PubMed ID: 14654606
[TBL] [Abstract][Full Text] [Related]
9. Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis.
Christensen RD; Malleske DT; Lambert DK; Baer VL; Prchal JT; Denson LE; Gerday E; Weaver Lewis KA; Shepherd JG
Neonatology; 2016; 109(1):1-5. PubMed ID: 26394287
[TBL] [Abstract][Full Text] [Related]
10. End-tidal carbon monoxide is predictive for neonatal non-hemolytic hyperbilirubinemia.
Okuyama H; Yonetani M; Uetani Y; Nakamura H
Pediatr Int; 2001 Aug; 43(4):329-33. PubMed ID: 11472573
[TBL] [Abstract][Full Text] [Related]
11. End-tidal carbon monoxide concentrations measured within 48 hours of birth predict hemolytic hyperbilirubinemia.
Cheng X; Lin B; Yang Y; Yu Y; Fu Y; Yang C
J Perinatol; 2024 Jun; 44(6):897-901. PubMed ID: 38627593
[TBL] [Abstract][Full Text] [Related]
12. Comparison of end-tidal carbon monoxide measurements with direct antiglobulin tests in the management of neonatal hyperbilirubinemia.
Elsaie AL; Taleb M; Nicosia A; Zangaladze A; Pease ME; Newton K; Schutzman DL
J Perinatol; 2020 Oct; 40(10):1513-1517. PubMed ID: 32203175
[TBL] [Abstract][Full Text] [Related]
13. Identification of risk for neonatal haemolysis.
Bhutani VK; Maisels MJ; Schutzman DL; Castillo Cuadrado ME; Aby JL; Bogen DL; Christensen RD; Watchko JF; Wong RJ; Stevenson DK
Acta Paediatr; 2018 Aug; 107(8):1350-1356. PubMed ID: 29532503
[TBL] [Abstract][Full Text] [Related]
14. Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia.
Bhutani VK; Srinivas S; Castillo Cuadrado ME; Aby JL; Wong RJ; Stevenson DK
Acta Paediatr; 2016 May; 105(5):e189-94. PubMed ID: 26802319
[TBL] [Abstract][Full Text] [Related]
15. Neonatal hyperbilirubinemia management: Clinical assessment of bilirubin production.
Du L; Ma X; Shen X; Bao Y; Chen L; Bhutani VK
Semin Perinatol; 2021 Feb; 45(1):151351. PubMed ID: 33308896
[TBL] [Abstract][Full Text] [Related]
16. Improvement Initiative: End-Tidal Carbon Monoxide Measurement in Newborns Receiving Phototherapy.
Bahr TM; Shakib JH; Stipelman CH; Kawamoto K; Lauer S; Christensen RD
J Pediatr; 2021 Nov; 238():168-173.e2. PubMed ID: 34260896
[TBL] [Abstract][Full Text] [Related]
17. Phototherapy increases hemoglobin degradation and bilirubin production in preterm infants.
Aouthmany MM
J Perinatol; 1999 Jun; 19(4):271-4. PubMed ID: 10685237
[TBL] [Abstract][Full Text] [Related]
18. End-tidal carbon monoxide and hemolysis.
Tidmarsh GF; Wong RJ; Stevenson DK
J Perinatol; 2014 Aug; 34(8):577-81. PubMed ID: 24743136
[TBL] [Abstract][Full Text] [Related]
19. Hemolysis and Glucose-6-Phosphate Dehydrogenase Deficiency-Related Neonatal Hyperbilirubinemia.
Kaplan M; Wong RJ; Stevenson DK
Neonatology; 2018; 114(3):223-225. PubMed ID: 29940590
[TBL] [Abstract][Full Text] [Related]
20. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
